GMP Storm Cloud: Generic Firms May Get Further Scrutiny After Actavis Recall

The latest in a series of recalls for Actavis' Little Falls, N.J. facility comes at an awkward time for the generics industry and FDA, and could fuel a congressional push towards tighter oversight of pharmaceutical production

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet